Acute bronchiolitis: The economic impact of non-compliance with national guidelines

被引:0
|
作者
Miranda, S. Poca [1 ,2 ]
Rodrigues, H. [1 ]
Oliveira, S. [2 ]
机构
[1] Hosp Santa Luzia, Pediat Dept, Unidade Local Saude Alto Minho, Viana Do Castelo, Portugal
[2] Univ Porto, Fac Econ, Porto, Portugal
关键词
Acute bronchiolitis; Clinical practice variations; Unjustified clinical practices; Economic burden; MANAGEMENT;
D O I
10.1016/j.jhqr.2024.06.005
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: Acute bronchiolitis is a common reason for admission to the pediatric emergency department. Evidence has shown that most interventions do not change the natural course of the disease. Material and methods: This study aimed to evaluate the economic impact of the noncompliance with the acute bronchiolitis Portuguese national guideline. A retrospective study of pediatric emergency episodes of a Portuguese hospital that had a diagnosis of acute bronchiolitis during 2019, was conducted. Results: The sample included 344 emergency episodes. Non-compliance with the guideline occurred in 71.8% of the episodes, mostly due to unjustified treatment. Following guideline in the studied hospital for one year would have resulted in an estimated overall 76.6% cost reduction, with a reduction in mean direct costs per patient of 14.93 <euro>, corresponding to a medium saving of 3.89 <euro> for each patient and a reduction of 11.03 <euro> for the Portuguese National Health Service. Analyzing the unjustified mean direct costs, of these 2.97 <euro> were related to inpatient diagnostic tests and therapeutic and the remaining 11.96 <euro> were related to outpatient therapy. Mean direct costs imputed to the patient for outpatient treatment represented only 3.31 <euro>, therefore most of mean direct costs is paid by the National Health Service. Conclusions: Compliance with guideline would allow the reduction of total estimated costs by about 76.6%, representing a waste of resources, without compromising the quality of care provided. Most of the cost associated with non-compliance with the guideline is justified by outpatient therapy, 67% of which was paid by the National Health Service. (c) 2024 FECA. Published by Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:299 / 305
页数:7
相关论文
共 50 条
  • [1] Non-compliance with national guidelines in the management of acute pancreatitis in the United Kingdom
    Aly, EAH
    Milne, R
    Johnson, CD
    DIGESTIVE SURGERY, 2002, 19 (03) : 192 - 198
  • [2] NATIONAL GUIDELINES FOR CAPSULE ENDOSCOPY: COST IMPLICATIONS OF NON-COMPLIANCE
    Cook, C.
    Hatton, C.
    Hendy, P.
    Makins, R.
    GUT, 2011, 60
  • [3] NON-COMPLIANCE WITH GUIDELINES FOR THE MANAGEMENT OF PULMONARY EMBOLISM: PREDICTORS AND IMPACT ON CLINICAL OUTCOME
    Chopard, Romain
    Cart, Lisbeth
    Badoz, Marc
    Ecarnot, Fiona
    Schiele, Francois
    Meneveau, Nicolas F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1928 - 1928
  • [4] IMPACT OF ATTRITION ON STUDIES OF NON-COMPLIANCE
    RAMSAY, J
    JOURNAL OF APPLIED PSYCHOLOGY, 1983, 68 (01) : 166 - 169
  • [5] Assessing the Impact of National Guidelines on the Management of Children Hospitalized for Acute Bronchiolitis
    McCulloh, Russell J.
    Smitherman, Sarah E.
    Koehn, Kristin L.
    Alverson, Brian K.
    PEDIATRIC PULMONOLOGY, 2014, 49 (07) : 688 - 694
  • [6] Pharmacoeconomic impact of non-compliance with statins
    Andrew M. Peterson
    William F. McGhan
    PharmacoEconomics, 2005, 23 : 13 - 25
  • [7] Pharmacoeconomic impact of non-compliance with statins
    Peterson, AM
    McGhan, WF
    PHARMACOECONOMICS, 2005, 23 (01) : 13 - 25
  • [8] Economic implications of non-compliance in health care
    Cleemput, I
    Kesteloot, K
    LANCET, 2002, 359 (9324): : 2129 - 2130
  • [9] Non-compliance with guidelines NICE is improving access to guidance
    Leng, Gillian
    BRITISH MEDICAL JOURNAL, 2011, 343